Review Article| Volume 31, ISSUE 2, P301-310, June 2011

Download started.


Sentinel Lymph Nodes in Cutaneous Melanoma


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kaur C.
        • Thomas R.J.
        • Desai N.
        • et al.
        The correlation of regression in primary melanoma with sentinel lymph node status.
        J Clin Pathol. 2008; 61: 297-300
        • Prieto V.G.
        Use of frozen sections in the examination of sentinel lymph nodes in patients with melanoma.
        Semin Diagn Pathol. 2008; 25: 112-115
        • Messina J.L.
        • Glass L.F.
        • Cruse C.W.
        • et al.
        Pathologic examination of the sentinel lymph node in malignant melanoma.
        Am J Surg Pathol. 1999; 23: 686-690
        • Creager A.J.
        • Shiver S.A.
        • Shen P.
        • et al.
        Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology.
        Cancer. 2002; 94: 3016-3022
        • Gershenwald J.E.
        • Colome M.I.
        • Lee J.E.
        • et al.
        Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
        J Clin Oncol. 1998; 16: 2253-2260
        • Clary B.M.
        • Brady M.S.
        • Lewis J.J.
        • et al.
        Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence.
        Ann Surg. 2001; 233: 250-258
        • Cochran A.J.
        Surgical pathology remains pivotal in the evaluation of ‘sentinel’ lymph nodes.
        Am J Surg Pathol. 1999; 23: 1169-1172
        • Prieto V.G.
        • Clark S.H.
        Processing of sentinel lymph nodes for detection of metastatic melanoma.
        Ann Diagn Pathol. 2002; 6: 257-264
        • Gibbs J.F.
        • Huang P.P.
        • Zhang P.J.
        • et al.
        Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes.
        Ann Surg Oncol. 1999; 6: 699-704
        • Yu L.L.
        • Flotte T.J.
        • Tanabe K.K.
        • et al.
        Detection of microscopic melanoma metastases in sentinel lymph nodes.
        Cancer. 1999; 86: 617-627
        • Shidham V.B.
        • Qi D.Y.
        • Acker S.
        • et al.
        Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
        Am J Surg Pathol. 2001; 25: 1039-1046
        • Abrahamsen H.N.
        • Hamilton-Dutoit S.J.
        • Larsen J.
        • et al.
        Sentinel lymph nodes in malignant melanoma: extended histopathologic evaluation improves diagnostic precision.
        Cancer. 2004; 100: 1683-1691
        • Shidham V.B.
        • Qi D.
        • Rao R.N.
        • et al.
        Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with ‘MCW Melanoma Cocktail’ - a mixture of monoclonal antibodies to MART-1, melan-A, and tyrosinase.
        BMC Cancer. 2003; 3: 15
        • Prieto V.G.
        • Shea C.R.
        Use of immunohistochemistry in melanocytic lesions.
        J Cutan Pathol. 2008; 35: 1-10
        • Trejo O.
        • Reed J.A.
        • Prieto V.G.
        Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation.
        J Cutan Pathol. 2002; 29: 397-406
        • Carson K.F.
        • Wen D.R.
        • Li P.X.
        • et al.
        Nodal nevi and cutaneous melanomas.
        Am J Surg Pathol. 1996; 20: 834-840
        • Lohmann C.M.
        • Iversen K.
        • Jungbluth A.A.
        • et al.
        Expression of melanocyte differentiation antigens and ki-67 in nodal nevi and comparison of ki-67 expression with metastatic melanoma.
        Am J Surg Pathol. 2002; 26: 1351-1357
        • Biddle D.A.
        • Evans H.L.
        • Kemp B.L.
        • et al.
        Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma.
        Am J Surg Pathol. 2003; 27: 673-681
        • Prieto V.G.
        • Diwan A.D.
        • Lazar A.F.J.
        • et al.
        Histologic quantification of tumor size in sentinel lymph node metastases correlates with prognosis in patients with cutaneous malignant melanoma.
        Mod Pathol. 2006; 19: 87A
        • Batistatou A.
        • Cook M.G.
        • Massi D.
        Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the dermatopathology Working Group of the European Society of Pathology.
        Virchows Arch. 2009; 454: 505-511
        • Cascinelli N.
        • Belli F.
        • Santinami M.
        • et al.
        Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience.
        Ann Surg Oncol. 2000; 7: 469-474
        • Gershenwald J.E.
        • Thompson W.
        • Mansfield P.F.
        • et al.
        Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
        J Clin Oncol. 1999; 17: 976-983
        • Rousseau Jr., D.L.
        • Ross M.I.
        • Johnson M.M.
        • et al.
        Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
        Ann Surg Oncol. 2003; 10: 569-574
        • Topping A.
        • Dewar D.
        • Rose V.
        • et al.
        Five years of sentinel node biopsy for melanoma: the St George's Melanoma Unit experience.
        Br J Plast Surg. 2004; 57: 97-104
        • Frankel T.L.
        • Griffith K.A.
        • Lowe L.
        • et al.
        Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?.
        Ann Surg Oncol. 2008; 15: 2403-2411
        • Page A.J.
        • Carlson G.W.
        • Delman K.A.
        • et al.
        Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
        Am Surg. 2007; 73 ([discussion: 678–9]): 674-678
        • Debarbieux S.
        • Duru G.
        • Dalle S.
        • et al.
        Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
        Br J Dermatol. 2007; 157: 58-67
        • Sabel M.S.
        • Griffith K.
        • Sondak V.K.
        • et al.
        Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
        J Am Coll Surg. 2005; 201: 37-47
        • Gershenwald J.E.
        • Andtbacka R.H.
        • Prieto V.G.
        • et al.
        Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.
        J Clin Oncol. 2008; 26: 4296-4303
        • Guggenheim M.
        • Dummer R.
        • Jung F.J.
        • et al.
        The influence of sentinel lymph node tumour burden on additional lymph node involvement and disease-free survival in cutaneous melanoma–a retrospective analysis of 392 cases.
        Br J Cancer. 2008; 98: 1922-1928
        • Dewar D.J.
        • Newell B.
        • Green M.A.
        • et al.
        The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.
        J Clin Oncol. 2004; 22: 3345-3349
        • Rossi C.R.
        • De Salvo G.L.
        • Bonandini E.
        • et al.
        Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.
        Ann Surg Oncol. 2008; 15: 1202-1210
        • van Akkooi A.C.
        • Bouwhuis M.G.
        • de Wilt J.H.
        • et al.
        Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma.
        Br J Surg. 2007; 94: 1293-1299
        • Wright B.E.
        • Scheri R.P.
        • Ye X.
        • et al.
        Importance of sentinel lymph node biopsy in patients with thin melanoma.
        Arch Surg. 2008; 143 ([discussion: 899–900]): 892-899
        • Guggenheim M.M.
        • Hug U.
        • Jung F.J.
        • et al.
        Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma.
        Ann Surg. 2008; 247: 687-693
        • Satzger I.
        • Völker B.
        • Al Ghazal M.
        • et al.
        Prognostic significance of histopathological parameters in sentinel nodes of melanoma patients.
        Histopathology. 2007; 50: 764-772
        • Romanini A.
        • Manca G.
        • Pellegrino D.
        • et al.
        Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome.
        Ann Oncol. 2005; 16: 1832-1840
        • Gradilone A.
        • Ribuffo D.
        • Silvestri I.
        • et al.
        Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance.
        Ann Surg Oncol. 2004; 11: 983-987
        • Mocellin S.
        • Hoon D.S.
        • Pilati P.
        • et al.
        Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis.
        J Clin Oncol. 2007; 25: 1588-1595
        • Scoggins C.R.
        • Ross M.I.
        • Reintgen D.S.
        • et al.
        Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
        J Clin Oncol. 2006; 24: 2849-2857
        • Hershko D.D.
        • Robb B.W.
        • Lowy A.M.
        • et al.
        Sentinel lymph node biopsy in thin melanoma patients.
        J Surg Oncol. 2006; 93: 279-285